About Us

Based on the experience of the founders, and recognizing the great need for an endoscopic solution for the treatment of Type 2 Diabetes, Endobetix was founded in 2012 and operates within the framework of Trendlines Medical, a technology incubator that is part of The Trendlines Group.

Management Team


Scientific and Clinical Advisors

  • Douglas Pleskow MD, AGAF, FASGE

    Associate Clinical Professor of Medicine, Harvard Medical School, Co-Director of Endoscopy, Beth Israel Deaconess Medical Center, Boston, MA
  • Randy J. Seeley, Ph.D. Donald C. Harrison Endowed

    Professor in Internal Medicine and Director of the Cincinnati Diabetes and Obesity Center, University of Cincinnati.

  • All Rights reserved. Endobetix Ltd.